The story of Viagra, formerly marketed by copyright, presents a fascinating case study for backers considering the healthcare arena . Despite its initial success and impact of billions in revenue , the patent end has opened the way for generic medications, significantly reducing income opportunities. This shift raises concerns about the future resi